One of the caveats for inhibiting apoptosis could be the emergence of chemoresistance that would promote growth in tumors with wild type p53. However, p53 is mutated in many cancers, and regardless; a mutant p53 protein undergoes acetylation, which also assists in tumor growth [46]. Here, TP53 is linked to neoplasm.